Author

Katherine Jongebloed

Observed institution: Canadian Critical Care Trials Group

OpenAlex ID: A5084327331

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial

2022 · Simin Florescu, Delia Stanciu, et al. · JAMA · 142

Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support–Free Days in Patients Hospitalized With COVID-19

2023 · Simin Florescu, Delia Stanciu, et al. · JAMA · 67

PDF

Intravenous Vitamin C for Patients Hospitalized With COVID-19

2023 · The LOVIT-COVID Investigators, on behalf of the Canadian Critical Care Trials Group, and the REMAP-CAP Investigators, Simin Florescu, et al. · JAMA · 57

PDF

The impact of a tailored nutrition intervention delivered for the duration of hospitalisation on daily energy delivery for patients with critical illness (INTENT): a phase II randomised controlled trial

2025 · Emma J. Ridley, Michael Bailey, et al. · Critical Care · 27

PDF

How much do we throw away in the intensive care unit? An observational point prevalence study of Australian and New Zealand ICUs

2023 · Matthew H. Anstey, Louise Trent, et al. · Critical Care and Resuscitation · 16

Critically ill patients having time outdoors: prevalence and resources in Australia and New Zealand

2024 · Matthew J. Maiden, Michelle Horton, et al. · Intensive Care Medicine · 4

Works count: 6

Citation count: 313

H-index: 5

I10-index: 5